<DOC>
	<DOCNO>NCT00416182</DOCNO>
	<brief_summary>Chronic sinusitis frequent complication cystic fibrosis . The aim study determine whether Pulmozyme ( dornase alfa ) would maintain sinus health ( compare placebo ) patient cystic fibrosis recently undergone sinus surgery .</brief_summary>
	<brief_title>Nasally Delivered Pulmozyme Sinusitis Cystic Fibrosis</brief_title>
	<detailed_description>AIM : To evaluate effectiveness Pulmozyme ( dornase alfa ) decrease post-operative sinusitis symptom patient cystic fibrosis ( CF ) PROCEDURES : 20 patient CF randomize receive either Pulmozyme placebo via nasal inhalation daily 12 month . Consent obtain follow surgery treatment begin 1 week post-operatively . Monitoring include examination record adverse effect follow weekly one month 2.5 , 6 , 9 12 month . Outcome measure include ciliary function testing , pulmonary function testing , sinus questionnaire CT scan .</detailed_description>
	<mesh_term>Fibrosis</mesh_term>
	<mesh_term>Cystic Fibrosis</mesh_term>
	<mesh_term>Sinusitis</mesh_term>
	<criteria>Clinical laboratory diagnosis cystic fibrosis Age great equal 5 year Forced expiratory volume 1 second ( FEV1 ) great equal 40 % predict Sinus surgery within one week enrollment Pregnancy Intolerance orally inhale Pulmozyme ( dornase alfa )</criteria>
	<gender>All</gender>
	<minimum_age>5 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>November 2014</verification_date>
	<keyword>Cystic fibrosis</keyword>
	<keyword>chronic sinusitis</keyword>
	<keyword>mucolytic</keyword>
</DOC>